Sangamo Therapeutics
Price & Volume
Stats
See more52W Range | $0.41-$3.17 |
Market Cap | $166.2M |
Shares Short | 14M |
Financials
See moreRevenue (12 Mos) | $81.7M |
Revenue Growth (YoY) | 5,042.1% |
Gross Profit (12 Mos) | -$22.7M |
Diluted EPS | -$0.26 |
News
See moreYahoo Finance • 19 days ago
Sangamo Therapeutics Presents Detailed Data from Registrational STAAR Study in Fabry Disease at International Congress of Inborn Errors of Metabolism 2025
Yahoo Finance • 2 months ago
Sangamo Therapeutics Inc (NASDAQ:SGMO) Reports Q2 2025 Earnings: Revenue Misses but Narrower-Than-Expected Loss
Yahoo Finance • 2 months ago
Sangamo Therapeutics Reports Recent Business Highlights and Second Quarter 2025 Financial Results
Yahoo Finance • 3 months ago
H.C. Wainwright Reaffirms Buy Rating on Sangamo After Promising Gene Therapy Data
About
CEO | Dr. Alexander D. Macrae Ch.B, M.B., MRCP, Ph.D. |
CFO | Ms. Prathyusha Duraibabu C.P.A., M.B.A. |
Address | 501 Canal Blvd, Richmond, CA, United States, 94804 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 183 |
